Botulinum Toxin Enhanced Foker Process for Long Gap Esophageal Atresia

Abstract

The traction-induced esophageal growth (Foker) process for the treatment of long gap esophageal atresia (LGEA) relies on applying progressive tension to the esophagus to induce growth. Due to its anti-fibrotic and muscle-relaxing properties, we hypothesize that Botulinum Toxin A (BTX) can enhance traction-induced esophageal growth.

Keywords

Hashtags

This article is published on an external journal. Click below to read the full text.